IFPMA 2015 interview series ‘Why taking flu shot should be your business’
Dr Abraham M. Palache, Influenza Scientist, Consultant at Abbott Biologicals and IFPMA Influenza Vaccine Supply International Task Force, talks about the importance of taking the flu shot. It is all about breaking misconceptions spread by anti-vaxxers. People most at risk should be given priority in receiving the flu shot. Find out who those most at risk are in this interview.
Among infectious diseases, flu is considered a leading killer. On average, worldwide, seasonal epidemics are said to result in some 3 to 5 million cases of severe illness, and about half a million deaths, according to the World Health Organization (WHO).
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations across the globe. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. The industry’s two million employees discover, develop, and deliver medicines and vaccines that advance global health.Learn more
Media ContactAbigail Jones firstname.lastname@example.org